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November 20101422 Abstracts(100-200 mg/d). The primary study end point was a change in intima-
media thickness of the common carotid artery after 2 years. Regression in
maximum left, maximum right, mean left, and mean right common carotid
artery intima-media thickness was greater with cilostazol than with aspirin
(–0.088  0.260 vs 0.059  0.275 mm, P  .001; –0.042  0.074 vs
0.045  0.216 mm, P  .03; –0.043  0.182 vs 0.028  0.202 mm, P 
.004; and –0.024  0.182 vs 0.048  0.169 mm, P  .001). Results
persisted when data were adjusted for possible confounding variables such as
hemoglobin A1C and lipid levels.
Comment: Cilostazol is a phosphodiesterase-3 inhibitor and has anti-
platelet, antithrombotic, and vasodilatory effects. It is approved for treat-
ment of claudication in the United States and for secondary prevention of
cerebral infarction in Asia. The ability of antiplatelet agents to serve as
effective primary prevention in patients with diabetes is controversial. This
study suggests that perhaps the wrong antiplatelet agent is being evaluated in
diabetic patients. Progression of intima-media thickness serves only as a
surrogate marker for progression of atherosclerosis and has not been shown
to predict clinical events in patients with type 2 diabetes. The results here are
interesting and suggest a large-scale prospective study of cilostazol for
primary prevention in type 2 diabetic patients should be considered.
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Conclusion: In both men and women, vital exhaustion independently
predicts long-term risk for adverse cardiac events.
Summary: Vital exhaustion is defined as a state of excessive fatigue,
increased irritability, and demoralization. European studies have suggested a
link between vital exhaustion and coronary heart disease. The authors
attempted to use data from the Atherosclerosis Risk In Communities
(ARIC) study to provide United States data on the role of vital exhaustion
and acute coronary syndromes. The goal was to determine whether individ-
uals with low exhaustion compared with those with high vital exhaustion
were at increased risk for myocardial infarction and fatal coronary heart
disease. ARIC participants were black or white men and women aged 48 to
67 years. ARIC is a large population-based prospective study of the causeand natural history of atherosclerosis. Patients are derived fromWashington
County, Maryland; suburban Minneapolis; Forsyth County, North Caro-
lina; and Jackson, Mississippi. Patients were initially enrolled between 1987
and 1989 and have returned at approximately 3-year intervals for three
follow-up clinical examinations. Hospitalizations and death during
follow-up are identified through annual telephone interviews and hospital
surveillance.
In this study, 12,895 participants in ARIC were monitored for occur-
rence of cardiac morbidity and mortality from 1990 to 2002 (maximum
follow-up, 13.0 years). Assessment of vital exhaustion was with the 21-item
Maastricht Questionnaire. Scores were divided in quartiles for statistical
analysis. Those scoring in the fourth quartile were considered to have high
vital exhaustion. High vital exhaustion predicted adverse cardiac events in
age-, gender-, and race-adjusted analyses (1.69, 95% confidence interval
[CI], 1.40-2.05). High vital exhaustion also predicted adverse cardiac events
when adjusted for educational level, body mass index, plasma low-density
lipoprotein and high-density lipoprotein cholesterol levels, systolic and
diastolic blood pressure, diabetes mellitus, smoking, and past years of
smoking (1.46, 95% CI, 1.20-1.79). Risks for adverse cardiac events in-
creased from the first to the fourth quartile of vital exhaustion, and proba-
bilities of adverse cardiac events were higher over time in patients with high
vital exhaustion compared with those with low exhaustion levels (P .002).
Vitally exhausted participants in this study, compared with nonexhausted
peers, were more likely to be women, black, and have less formal education.
Comment:Vital exhaustion is closely linked to depression, and the two
conditions share common characteristics such as irritability and fatigue.
Fatigue does appear to be a real and measurable risk factor for cardiovascular
disease. Clearly, fatigue is associated with myocardial infarction. This is
especially so in women:70% of women in a recent study reported unusual
fatigue before myocardial infarction, with about 30% of men reporting
fatigue preceding myocardial infarction (McSweeney JC, et al, Circulation
2003;108:2619- 23). Other studies have also suggested an inverse relation-
ship between exhaustion and social and economic status (Schuitemaker GE,
et al, Psychosomatics 2004;45:414-8). TheMaastricht Questionnaire exam-
ines only the presence or absence of vital exhaustion but not the etiology. It
is possible that residual or unmeasured confounders, such as the underlying
etiology of vital exhaustion, may be additive risk factors for cardiovascular
events.
